Trends in Reduced Hospitalizations: Research Update

research in reduced hospitalizations with RPM

Reduced hospitalizations are one of the clearest goals of remote patient monitoring (RPM). When care teams can see blood pressure, weight, oxygen saturation, and symptoms between visits, they are able to track changes in health data between office visits. Treatment plans can be managed. Patients stay home. Families avoid a stressful trip to the emergency department.

Meta-analyses of large health system programs, and randomized trials published in 2025 and 2026 have provided insights into reduced hospitalizations. Several findings point toward fewer admissions and shorter stays. Some studies show where programs need a different design. Both are worth reviewing if you run a monitoring program or plan to start one.

This article reviews research on reduced hospitalizations with remote patient monitoring, what some programs do differently to help reduce hospitalizatons, and the questions providers ask most often.

The Importance of Reduced Hospitalizations 

Reduced hospitalizations mean more days at home, fewer disruptions to daily life, and less exposure to hospital-acquired risks. For people living with heart failure, COPD, or diabetes, one admission can set off a chain of setbacks. Strength declines. Medications change. The chance of returning within a month goes up.

Readmissions are common. According to AHRQ data, U.S. hospitals recorded about 3.8 million 30-day all-cause adult readmissions in 2018. Many involve chronic conditions that worsen gradually, over days rather than hours. That slow build is where home monitoring helps most.

For care teams, fewer avoidable admissions free up clinical time and hospital capacity. For organizations in value-based arrangements, patient outcomes and cost of care tend to move together. The patient benefit comes first, and the rest follows from it.

How Remote Patient Monitoring Supports Reduced Hospitalizations

Remote patient monitoring connects patients to their care team through devices at home. A patient steps on a scale, takes a blood pressure reading, or checks oxygen levels. The reading travels to a clinical platform, where nurses or other clinicians review it.

The value lies in the pattern over time. A weight gain of a few pounds over several days may signal fluid retention in heart failure. A falling oxygen level paired with a rising heart rate can point to an early COPD exacerbation. A run of high blood pressure readings may call for a medication adjustment.

Each of these trends can surface days before symptoms send someone to the hospital. Tracking vital signs daily gives clinicians time to call the patient, adjust a prescription, or schedule a same-week visit.

Most programs follow the same basic sequence.

  1. Patients take readings at home with cellular or Bluetooth devices.
  2. Data transmits automatically to the care team’s platform.
  3. Clinicians review the readings and flag any outside set thresholds.
  4. The care team contacts the patient and acts on what they find.

Step four drives reduced hospitalizations. Data creates the opportunity. A clinician’s response turns it into better care.

What Research Shows on Reduced Hospitalizations

The past two years brought several new studies on remote patient monitoring and hospital use. Here is what some studies have shown.

A 2025 Meta-Analysis Across Chronic Conditions

A 2025 systematic review and meta-analysis in JMIR mHealth pooled randomized controlled trials of remote patient monitoring for noncommunicable diseases. Conditions included chronic lung disease, diabetes, cardiovascular disease, cancer, and mental health disorders.

Compared with usual care, a smaller share of RPM patients were hospitalized (risk ratio 0.86). Hospital stays were shorter by about 0.81 days on average. Patients in monitoring programs also had possibly more outpatient visits.

That last point deserves attention. More outpatient contact alongside fewer inpatient days suggests care is shifting to a lower-acuity setting. The authors rated the certainty of the evidence as low, so larger trials are needed to confirm the size of these effects. The direction, though, is consistent.

Geisinger’s Readmission Prevention Program

A study in The Permanente Journal, published online in December 2025, examined an RPM program at Geisinger. The program started during the COVID-19 pandemic and later expanded to other high-risk patients after discharge. Participants were members of Geisinger Health Plan or Keystone Accountable Care Organization.

The primary outcome was 30-day all-cause readmissions. Enrolled patients had an 11% readmission rate. Patients who did not enroll had a rate of 41%. That is a 30-point absolute difference.

The authors describe their study group as a convenience sample. Patients who choose to enroll may differ from those who decline, and that likely shaped the results. Even with that limitation, a gap this large is hard to set aside.

Michigan Medicine’s Patient Monitoring at Home

Michigan Medicine’s Patient Monitoring at Home program remains one of the largest real-world RPM studies. Published in Telemedicine and e-Health, it analyzed 1,139 patient encounters from November 2020 through August 2022. Patients received a cellular tablet and Bluetooth devices. Registered nurses reviewed their data seven days a week.

Hospital admissions fell 59% in the six months after enrollment, from an average of 1.38 to 0.57. When researchers excluded COVID-19 patients, the relative reduction was still 49%. About three in four patients enrolled right after a hospital stay. The drop in admissions held after patients mailed their kits back.

Heart Failure and Structured Remote Management

Heart failure has the deepest body of RPM evidence. The TIM-HF2 randomized trial, published in The Lancet, enrolled 1,538 patients in Germany who had been hospitalized for heart failure within the prior year. Patients sent daily readings to a telemedical center that worked directly with their cardiologist and primary care physician.

Patients in the remote management group lost an average of 17.8 days per year to unplanned cardiovascular admissions or death. The usual care group lost 24.2 days. Much of that difference came from lower mortality. For patients and families, that outcome matters just as much.

COPD and Unplanned Admissions

A pre-post study in the International Journal of Chronic Obstructive Pulmonary Disease followed 126 patients at a large outpatient pulmonary practice. Each had at least one unplanned hospitalization or emergency visit in the year before starting remote cardiorespiratory monitoring.

All-cause hospitalizations dropped 65%, from 137 in the year before monitoring to 48 in the year after. Per patient, the rate fell from 1.09 to 0.38 hospitalizations a year. Emergency department visits per patient did not change significantly. For a disease marked by sudden flare-ups, fewer admissions is still a strong signal.

Where the Research on Reduced Hospitalizations Is Mixed

Some patient groups respond differently to remote monitoring, and newer trials are starting to show why. The ACCOMPLISH trial, published in JAMA Network Open in June 2026, randomized 1,286 adults discharged after sepsis or lower respiratory tract infection. It compared four remote monitoring approaches with usual care at UPMC.

Days spent at home over the 90 days after discharge were similar across all groups. Among patients 65 and up, and those discharged to a skilled nursing facility, monitoring was associated with fewer days at home and higher readmission rates. Younger patients who went directly home showed a trend toward benefit.

Patients in follow-up interviews said they found monitoring reassuring. Many also questioned whether it helped resolve their problems. The authors called for tailoring remote monitoring to each patient’s needs.

This trial adds useful context. Recovery from a serious infection may follow a different course than a chronic condition, where weight or blood pressure tends to drift over days. The practical lesson for program leaders is clear. Match the monitoring model to the condition, the patient, and the response your team can deliver.

What Programs With Reduced Hospitalizations Have in Common

Across these studies, the programs that achieved reduced hospitalizations shared several traits.

  1. They selected the right patients. Strong results came from people with chronic conditions that change gradually, such as heart failure, COPD, and hypertension, often after a recent admission.
  2. They reviewed data every day. Michigan’s nurses checked readings seven days a week, and TIM-HF2 ran a dedicated telemedical center.
  3. They escalated quickly. A reading outside range led to a call, a medication change, or a visit, with clear ownership of who acts and when.
  4. They enrolled patients early. Starting at discharge covers the weeks when readmission risk is highest.
  5. They used simple devices. Patients take readings more consistently when a device works out of the box, with no app, Wi-Fi, or Bluetooth pairing.
  6. They kept patients involved. Regular check-ins and caregiver support drive better patient engagement and steadier data.

These traits apply well beyond the hospital discharge window. They form the backbone of effective chronic disease management programs, where the goal is to keep patients stable month after month.

How This Research Fits the Wider Evidence Base

The studies in this update sit within a larger body of research on care at home. Our review of recent digital health study findings covers heart failure meta-analyses, aging in place, and diabetes control. Taken together, the research shows that monitoring works best when paired with a responsive care model.

Device choice plays a quiet but real role in that model. Tenovi offers standalone cellular devices with their own SIMs, plus Bluetooth devices that connect through the Tenovi Cellular Gateway. Readings flow automatically to the platforms care teams already use. Patients don’t need a smartphone or home internet, which helps programs reach rural and underserved communities.

Frequently Asked Questions About Reduced Hospitalizations With RPM

Providers and program leaders often have practical questions about reduced hospitalizations with remote patient monitoring. This section covers how RPM lowers admissions, which patients benefit most, when to start monitoring, and why some studies show different results.

1) How does remote patient monitoring lead to reduced hospitalizations?

Remote patient monitoring gives care teams daily readings between visits. Clinicians can spot early warning signs, such as weight gain or falling oxygen levels, and intervene before a patient needs emergency care. The care team’s response is what turns that data into fewer admissions.

2) Which conditions show the strongest evidence for reduced hospitalizations?

Heart failure has the most extensive evidence, including large randomized trials. COPD and hypertension programs have also reported fewer admissions. These conditions tend to worsen gradually, which gives clinicians time to act on trends.

3) How soon after discharge should remote monitoring start?

Many successful programs enroll patients at discharge or within days of it. In the Michigan Medicine study, about three in four patients enrolled right after a hospital stay. The first weeks home carry the highest readmission risk, so early enrollment covers that window.

4) Does remote patient monitoring reduce emergency department visits?

Results vary by program and population. Some studies report fewer emergency visits alongside fewer admissions. A COPD study found fewer hospitalizations but no significant change in emergency visits, so outcomes depend on the condition and the program design.

5) Why do some remote monitoring studies show no benefit?

Program design and patient fit matter. A 2026 trial in patients recovering from sepsis found no overall benefit, and patients 65 and up had more readmissions. The authors recommended tailoring monitoring to each patient’s needs rather than applying one model to everyone.

6) What devices do patients need for remote patient monitoring?

Common devices include blood pressure monitors, weight scales, pulse oximeters, and glucose meters. Cellular-connected devices send readings automatically without apps, Wi-Fi, or Bluetooth pairing. That simplicity helps patients take readings consistently.

Understanding Reduced Hospitalizations With Remote Patient Monitoring

The research on reduced hospitalizations continues to build. A 2025 meta-analysis found fewer patients hospitalized and shorter stays with remote patient monitoring. Programs at Geisinger and Michigan Medicine reported large drops in readmissions and admissions. Heart failure and COPD studies point the same way. A 2026 sepsis trial shows that design matters, especially for patients 65 and up. The programs that succeed select the right patients, review data daily, respond fast, and keep devices simple.

Tenovi provides cellular-connected remote patient monitoring and remote therapeutic monitoring devices, fulfillment, and data integration for RPM software companies, care management companies, telehealth platforms, health systems, payers, and pharmacies. Our devices help care teams get reliable readings from patients at home so they can act early. Contact us for a free demo and consultation to see how Tenovi can support your program.

Want to dig deeper? Get our FREE quick start guide to understanding RPM.

Learn how remote patient monitoring works, device and platform features, and how to seamlessly connect with fulfillment and data APIs. 

Download the RPM Quick Start guide by filling out the form below.